We are live on ! Find out more
IMVT icon

Immunovant
IMVT

115 hedge funds and large institutions have $1.37B invested in Immunovant in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

255% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 11

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

165% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 20

96% more capital invested

Capital invested by funds: $696M → $1.37B (+$670M)

32% more funds holding

Funds holding: 87 → 115 (+28)

2% more ownership

Funds ownership: 43.23% → 45.23% (+2%)

Holders
115
Holders Change
+28
Holders Change %
+32.18%
% of All Funds
2.32%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.12%
New
39
Increased
53
Reduced
20
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$53.9M
2
CAM
Cormorant Asset Management
Massachusetts
+$49.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$44.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$41M
5
BlackRock
BlackRock
New York
+$36.9M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$31.9M
2
LGM
Logos Global Management
California
-$15.2M
3
RG
Redmile Group
California
-$14.4M
4
CCM
Camber Capital Management
Massachusetts
-$10.9M
5
O
OrbiMed
New York
-$8.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
51
Moore Capital Management
New York
$1.93M +$1.65M +54,834 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$1.86M +$722K +24,018 +83%
MIM
53
Monashee Investment Management
Massachusetts
$1.76M +$1.5M +50,000 New
SSA
54
Schonfeld Strategic Advisors
New York
$1.58M +$316K +10,512 +31%
CS
55
Credit Suisse
Switzerland
$1.38M +$773K +25,708 +192%
BFM
56
Boothbay Fund Management
New York
$1.37M +$106K +3,525 +10%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$1.33M +$447K +14,849 +65%
Arrowstreet Capital
58
Arrowstreet Capital
Massachusetts
$1.32M +$1.12M +37,400 New
PPA
59
Parametric Portfolio Associates
Washington
$1.27M +$1.09M +36,085 New
EI
60
EAM Investors
California
$1.25M +$1.06M +35,393 New
Bank of America
61
Bank of America
North Carolina
$1.18M +$645K +21,453 +179%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$1.11M +$424K +14,100 +81%
State of Wisconsin Investment Board
63
State of Wisconsin Investment Board
Wisconsin
$1.08M +$923K +30,700 New
SEI Investments
64
SEI Investments
Pennsylvania
$910K +$777K +25,850 New
CSS
65
Cubist Systematic Strategies
Connecticut
$870K +$609K +20,240 +451%
Macquarie Group
66
Macquarie Group
Australia
$798K +$654K +21,757 +2,415%
Federated Hermes
67
Federated Hermes
Pennsylvania
$769K +$658K +21,866 New
Rafferty Asset Management
68
Rafferty Asset Management
New York
$758K +$648K +21,535 New
Deutsche Bank
69
Deutsche Bank
Germany
$742K -$2.92M -97,021 -82%
AIG
70
American International Group
New York
$735K +$276K +9,188 +79%
UBS AM
71
UBS AM
Illinois
$704K +$334K +11,100 +125%
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$673K +$241K +8,000 +72%
HS
73
HighVista Strategies
Massachusetts
$630K +$539K +17,905 New
JP Morgan Chase
74
JP Morgan Chase
New York
$627K +$34.3K +1,142 +7%
Squarepoint
75
Squarepoint
New York
$620K +$530K +17,610 New
1 2
3
4 5

IMVT Hedge Fund Activity: Q3 2020 in Review

115 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q3 2020, worth a combined $1.37B — up 96% from $696M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IMVT positions and 11 closed out — a net gain of 28 holders — while 53 added to existing stakes and 20 trimmed.

The largest buyer was RTW Investments, adding an estimated $53.9M. The largest seller was Adage Capital Partners, cutting an estimated $31.9M.

  • 115 institutional investors held Immunovant (IMVT) as of Q3 2020, up from 87 in Q2 2020.
  • Funds reported $1.37B of Immunovant stock for Q3 2020, up 96% quarter-over-quarter.
  • 39 funds opened new Immunovant positions in Q3 2020 and 11 closed out, a net change of +28 holders.
  • The largest Immunovant buyer in Q3 2020 was RTW Investments, an estimated $53.9M added.
  • The largest Immunovant seller in Q3 2020 was Adage Capital Partners, an estimated $31.9M sold.

Based on aggregated 13F filings for Q3 2020.